Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peijia Xu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 25, 2020
Cancer neoantigen: Boosting immunotherapyPeijia Xu, Haiqing Luo, Ying Kong, et al.
Investigational New Drugs|March 15, 2022
Actively targeted delivery of SN38 by ultrafine iron oxide nanoparticle for treating pancreatic cancerTing Xue, Peijia Xu, Jonathan Padelford, et al.
Molecular Diversity|February 13, 2025
Discovery of novel covalent stabilizers for p53 Y220C using structure-based drug discovery methodsYiming Wen, Peijia Xu, Yijie Chen, et al.
ACS Medicinal Chemistry Letters|August 16, 2023
Structure-Activity Relationship Study of 1<i>H</i>-Pyrrole-3-carbonitrile Derivatives as STING Receptor AgonistsChang Shen, Peijia Xu, Changfa Zhang, et al.
Journal of Medicinal Chemistry|May 9, 2025
Discovery of 3-(Fluoro-imidazolyl)pyridazine Derivatives as Potent STING Agonists with Antitumor ActivityHui Hou, Jingyi Zhou, Qibang Sui, et al.
Journal of Medicinal Chemistry|February 22, 2023
Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor AgonistsBin Shan, Hui Hou, Keke Zhang, et al.
Circulation Research|March 20, 2026
Inhibiting RhoA Activation Via GDP-State Stabilization to Relieve Heart FailureMengzhu Xue, Yingquan Liang, Zhen Yuan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 25, 2020
Cancer neoantigen: Boosting immunotherapyPeijia Xu, Haiqing Luo, Ying Kong, et al.
Investigational New Drugs|March 15, 2022
Actively targeted delivery of SN38 by ultrafine iron oxide nanoparticle for treating pancreatic cancerTing Xue, Peijia Xu, Jonathan Padelford, et al.
Molecular Diversity|February 13, 2025
Discovery of novel covalent stabilizers for p53 Y220C using structure-based drug discovery methodsYiming Wen, Peijia Xu, Yijie Chen, et al.
ACS Medicinal Chemistry Letters|August 16, 2023
Structure-Activity Relationship Study of 1<i>H</i>-Pyrrole-3-carbonitrile Derivatives as STING Receptor AgonistsChang Shen, Peijia Xu, Changfa Zhang, et al.
Journal of Medicinal Chemistry|May 9, 2025
Discovery of 3-(Fluoro-imidazolyl)pyridazine Derivatives as Potent STING Agonists with Antitumor ActivityHui Hou, Jingyi Zhou, Qibang Sui, et al.
Journal of Medicinal Chemistry|February 22, 2023
Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor AgonistsBin Shan, Hui Hou, Keke Zhang, et al.
Circulation Research|March 20, 2026
Inhibiting RhoA Activation Via GDP-State Stabilization to Relieve Heart FailureMengzhu Xue, Yingquan Liang, Zhen Yuan, et al.
Pageof 1